Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4)

NCT06107010 is registered in ClinicalTrials.gov with Wandercraft as lead sponsor.

NCT NCT06107010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06107010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4)
Lead sponsor
Wandercraft
Phase
Not applicable
Overall status
Recruiting
Start date
June 12, 2023
Completion date
February 28, 2026
Enrollment
66 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident, cerebrovascular disorders, hemiparesis, hemiparesis/hemiplegia (one sided weakness/paralysis), hemiparesis;poststroke/cva, stroke hemorrhagic, stroke, acute, stroke, ischemic, stroke, subacute